PCK.AU · PainChek Limited

-

Please sign in to comment on PCK.AU

1 Comment

Admin

4 years, 1 month ago

PainChek Limited is currently in a long term downtrend where the price is trading 21.4% below its 200 day moving average.

From a valuation standpoint, the stock is 113.0% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 548.4.

PainChek Limited's total revenue sank by 30.9% to $127K since the same quarter in the previous year.

Its net income has increased by 86.3% to $-1M since the same quarter in the previous year.

Finally, its free cash flow fell by 45.0% to $-2M since the same quarter in the previous year.

Based on the above factors, PainChek Limited gets an overall score of 1/5.

Exchange	AU
CurrencyCode	AUD
ISIN	AU000000PCK6
Sector	Healthcare
Industry	Health Information Services

Market Cap	64M
PE Ratio	None
Target Price	0.08
Beta	0.44
Dividend Yield	None

ABOUT

PainChek Limited

PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, which uses cameras in smartphones and tablets for a facial scan that is analyzed in real time using facial recognition software to indicate the presence of pain. It serves patients suffering with dementia and pre-verbal infants; and the aged care, disability, home care, hospital, and infant sectors. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.

PCK.AU · PainChek Limited

-

PainChek Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest PainChek Limited using a moving average strategy